Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease

Completed

Conditions studied: Ulcerative Colitis, Crohn's Disease

In brief

Hypothesis: Mesalamine is commonly used to induce and maintain remission in patients with Inflammatory Bowel Disease (IBD). Behavioral and psycho-social barriers to mesalamine adherence exist in patients with IBD. These factors can be identified using qualitative testing in order to develop a validated instrument to measure the "adherence profile" of an individual patient, and design appropriate behavioral interventions to reduce non-adherence. Objectives: To test a novel interview instrument that determines the medication adherence profile of patients with IBD prescribed mesalamine by correlating with objective measures of adherence

Key facts

Study ID

NCT01349504

Run by

Beth Israel Deaconess Medical Center

People needed

106

Starts

2011-04-01

Expected to finish

2012-12-01

Last updated by the study team

2013-08-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patient (age >18)
• Diagnosis of IBD (confirmed by endoscopy and histology) > 3 months
• In clinical remission (based on Simple Colitis Activity Index score <2.5)
• On mesalamine compound for maintenance of remission
• Stable mesalamine dose for 1 month

You may not qualify if…

• Not receiving primary GI care at BIDMC

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.